Atlas Trials

Extension Study of PRX-102 for up to 60 Months

Clinical trial NCT01981720 · COMPLETED

Trial details

NCT number
NCT01981720
Sponsor
Protalix
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Fabry Disease
Start date
2014-01-16
Primary completion
2020-08-26
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.